Abstract
The Pharmaceutical policy in China has changed greatly since the National Essential Medicines Program (NEMP) introduced the health system reform in 2009. A National Essential Medicine List (NEML) was issued in 2009, with 307 medicines. The second edition of NEML with 520 medicines was issued in 2012, and the third edition with 685 medicines in 2018. Other matching policies were introduced consequently, such as Zero Mark-up (essential medicines are sold to patients for procurement price plus a fixed distribution cost, with no profit for the sale to the health facility), province-based medicine, competitive-bidding system and so on. The Center of Drug Safety and Policy (CDSP), situated in Xi’an Jiaotong University (XJTU) and founded in 2014, is working on pharmaceutical policy issues and providing the necessary evidence showing the efficiency of these policies. The results of these studies are reported in this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
United Nations Development Group and United Nations. (2003). Indicators for monitoring the millennium development goals: definitions, rationale, concepts and sources (Vol. 95). United Nations Publications.
Suh, G.H. (2011). High medicine prices and poor affordability. Current opinion in psychiatry, 24(4):341–345.
Paphitou, N.I. (2013). Antimicrobial resistance: action to combat the rising microbial challenges. International journal of antimicrobial agents, 42:S25–S28.
World Health Organization. (2001). How to develop and implement a national drug policy. Geneva: World Health Organization.
Traulsen, J.M., Almarsdóttir, A.B. (2005). The argument for pharmaceutical policy. Pharmacy World and Science, 27(1): 7–12.
Perehudoff, S.K., Alexandrov, N.V., Hogerzeil, H.V. (2019). Access to essential medicines in 195 countries: A human rights approach to sustainable development. Global public health, 14(3): 431–444.
Espin, J., Rovira, J. de Labry, A.O. (2011). Review series on pharmaceutical pricing policies and interventions: working paper 1: external reference pricing. WHO/HAI.
Acosta, A., Ciapponi, A., Aaserud, M., Vietto, V., Austvoll-Dahlgren, A., Kösters, J.P et al. (2014). Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Cochrane Database of Systematic Reviews, 10:CD005979.
Ritter, A. (2009). How do drug policy makers access research evidence? International Journal of Drug Policy, 20(1):70–75.
Wang, S., Zhu, J., Gao, Z., Wu, W., and Yao, L. (2018). Discussion on key drugs in shortage and their supply safeguard measures. Chin. Pharm. Aff, 8:1034–1042.
Jiang, M., Zhou, Z., Wu, L., Shen, Q., Lv, B., Wang, X., et al. (2015). Medicine prices, availability, and affordability in the Shaanxi Province in China: implications for the future. International journal of clinical pharmacy, 37(1), 12–17.
Fang, Y., Wagner, A.K., Yang, S., Jiang, M., Zhang, F., Ross-Degnan, D. (2013). Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China. The Lancet Global Health, 1(4):e227–e237.
Górski, J., Chaisse, J, Chi, M. (2017). One Belt One Road Initiative (“OBOR”): Editorial. Transnational Dispute Management, 14(3). Available at SSRN: https://ssrn.com/abstract=3051785.
Quick, J.D., Hume, M.L., Rankin, J.R., O’Connor, R.W., Rankin, J.R., O’Connor, R. W. (1997). Managing Drug Supply Management Sciences for Health.
Husereau, D.R., & Cameron, C.G. (2012). Value-Based Pricing of Pharmaceuticals in Canada: Opportunities to Expand the Role of Health Technology Assessment? Canadian Health Services Research Foundation.
World Health Organization. (2004). WHO medicines strategy 2004–2007: countries at the core (No. WHO/EDM/2004.5). Geneva: World Health Organization.
World Health Organization. (2008). Measuring medicine prices, availability, affordability and price components (No. WHO/PSM/PAR/2008.3). Geneva: World Health Organization.
Ogurtsova, K., da Rocha Fernandes, J.D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N.H., et al. (2017). IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinical practice, 128:40–50.
Yang, C., Hu, S., Zhu, Y., Zhu, W., Li, Z., Fang, Y. (2019). Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China. PloS One, 14(10): e0223769.
Li, Z., Feng, Q., Kabba, J.A., Yang, C., Chang, J., Jiang, M., et al. (2019). Prices, availability and affordability of insulin products: a cross-sectional survey in Shaanxi Province, western China. Tropical Medicine & International Health, 24(1):43–52.
Saeed A, Saeed H, Saleem Z, Fang Y, Babar Z-U-D. (2019). Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology. PloS One, 14(4): e0216122. https://doi.org/10.1371/journal.pone.0216122.
Gray A, Manasse HR Jr. (2012). Shortages of medicines: a complex global challenge. Bulletin of World Health Organization, 90(3): 158±158A.
Wu, L., Fang, Y., Yang, C., Shen, Q., Chang, J., Zhu, W., et al. (2016). A review of research on drug shortages in China. Chin. Pharm. Aff, 5:458–465.
Yang, C., Wu, L., Cai, W., Zhu, W., Shen, Q., Li, Z., et al. (2016). Current situation, determinants, and solutions to drug shortages in Shaanxi Province, China: a qualitative study. PloS One, 11(10): e0165183.
Yang, C., Cai, W., Li, Z., Page, A.T., Fang, Y. (2018). The current status and effects of emergency drug shortages in China: Perceptions of emergency department physicians. PloS One, 13(10): e0205238.
Xiong, K., Chen, H., Zhang, Z., and Xu, J. (2019). Feasibility demonstration and comparative study of “Two-Vote System” of pharmaceutical procurement of public medical institutions. Chin. Hosp. Manage, 2: 21–23.
Hu, S. (2017). The Theory and practice of “Two-Invoice System” in the drug procurement. China Academic Journal Electronic Publishing House, 4:8–10.
NHFPC. Notice on the procurement and supply of emergency medicine. Division of Drug Policy and Essential Drug Policy. Beijing: China’s National Health and Family Planning Commission, 2015.
Hu, S., Chen, C., Yuan, S., Xue, F., Shi, L., Fang, Y., et al. (2019). The effects of a new public medicine procurement policy on medicine price in China: an interrupted time series analysis. Frontiers in Pharmacology, 10: 950.
Yang, C., Shen, Q., Cai, W., Zhu, W., Li, Z., Wu, L., et al. (2017). Impact of the zero-markup drug policy on hospitalisation expenditure in western rural China: an interrupted time series analysis. Tropical Medicine & International Health, 22(2):180–186.
Zhai, P., Li, Q., Gillani, A.H., Hayat, K., Shi, L., Wang, S., et al. (2019). The impact of short message services and personal consultation by pharmacy students on medication adherence and blood pressure control: study protocol for a cluster randomized trial. Patient Preference and Adherence, 13:627.
Rice, L.B. (2018). Antimicrobial stewardship and antimicrobial resistance. Medical Clinics, 102(5):805–818.
O’Neill, J. (2016). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. [cited 2019 December 1]; Available from: https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf
Centers for Disease Control and Prevention. Antibiotic/Antimicrobial Resistance. 2016 [Cited 2019 August 20]; Available from: https://www.cdc.gov/drugresistance/
Carlin, K., Lofmark, S., Blad, L. (2014). Swedish work on containment of antibiotic resistance. Public Health Agency of Sweden: Stockholm, Sweden.
Ye, D., Chang, J., Yang, C., Yan, K., Ji, W., Aziz, M.M., et al. (2017). How does the general public view antibiotic use in China? Result from a cross-sectional survey. International Journal of Clinical Pharmacy, 39(4): 927–934.
Gillani, A., Ji, W., Hussain, W., Imran, A., Chang, J., Yang, C. et al. (2017). Antibiotic self-medication among Non-Medical University Students in Punjab, Pakistan: a cross-sectional survey. International Journal of Environmental Research and Public Health, 14(10):1152.
Aziz, M.M., Masood, I., Yousaf, M., Saleem, H., Ye, D., Fang, Y. (2018). Pattern of medication selling and self-medication practices: A study from Punjab, Pakistan. PloS One, 13(3): e0194240.
World Health Organization. (2015). Antibiotic resistance: multi-country public awareness survey. [cited 2019 November 1]; Available from: Available at: http://apps.who.int/iris/bitstream/10665/194460/1/9789241509817_eng.pdf
Morgan, D.J., Okeke, I.N., Laxminarayan, R., Perencevich, E.N., Weisenberg, S. (2011). Non-prescription antimicrobial use worldwide: a systematic review. The Lancet infectious diseases, 11(9): 692–701.
Chang, J., Ye, D., Lv, B., Jiang, M., Zhu, S., Yan, K., et al. (2017). Sale of antibiotics without a prescription at community pharmacies in urban China: a multicentre cross-sectional survey. Journal of Antimicrobial Chemotherapy, 72(4):1235–1242.
Zawahir, S., Lekamwasam, S., Aslani, P. (2019). Antibiotic dispensing practice in community pharmacies: A simulated client study. Research in Social and Administrative Pharmacy, 15(5):584–590.
Zapata-Cachafeiro, M., Piñeiro-Lamas, M., Guinovart, M.C., López-Vázquez, P., Vázquez-Lago, J.M., & Figueiras, A. (2018). Magnitude and determinants of antibiotic dispensing without prescription in Spain: a simulated patient study. Journal of Antimicrobial Chemotherapy, 74(2):511–514.
Fitzpatrick, A., Tumlinson, K. (2017). Strategies for optimal implementation of simulated clients for measuring quality of care in low-and middle-income countries. Global Health: Science and Practice, 5(1):108–114.
Watson, M.C., Norris, P., Granas, A.G. (2006). A systematic review of the use of simulated patients and pharmacy practice research. International Journal of Pharmacy Practice, 14(2): 83–93.
Chang, J., Xu, S., Zhu, S., Li, Z., Yu, J., Zhang, Y., et al. (2019). Assessment of non-prescription antibiotic dispensing at community pharmacies in China with simulated clients: a mixed cross-sectional and longitudinal study. The Lancet Infectious Diseases, 19(12):1345–1354.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 The Author(s)
About this chapter
Cite this chapter
Yang, C., Saeed, A., Hayat, K., Lambojon, KM., Gillani, A.H., Fang, Y. (2020). Pharmaceutical Policy and Practice Research: A Review of Studies in China. In: Babar, ZUD. (eds) Global Pharmaceutical Policy. Palgrave Macmillan, Singapore. https://doi.org/10.1007/978-981-15-2724-1_11
Download citation
DOI: https://doi.org/10.1007/978-981-15-2724-1_11
Publisher Name: Palgrave Macmillan, Singapore
Print ISBN: 978-981-15-2723-4
Online ISBN: 978-981-15-2724-1
eBook Packages: Social SciencesSocial Sciences (R0)